Research graph
References from Overcoming Primary Graft Failure in Pediatric Allogeneic HSCT: Insights from Ten Centers of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC). Local targets link to admitted publications; unresolved targets remain external evidence.
Indications for haematopoietic cell transplantation and CAR-T for haematological diseases, solid tumours and immune disorders: 2025 EBMT practice recommendations
10.1038/s41409-025-02701-3 · 2025 · External reference
The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation
10.1038/s41409-017-0062-8 · 2018 · External reference
Risk Factors, Clinical Outcomes, and Cost-of-Care Related to Graft Failure in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients
10.1016/j.bbmt.2020.03.009 · 2020 · External reference
Incidence, Management, and Prognosis of Graft Failure and Autologous Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation
10.3346/jkms.2021.36.e151 · 2021 · External reference
Graft failure in the modern era of allogeneic hematopoietic SCT
10.1038/bmt.2012.239 · 2013 · External reference
Poor graft function after allogeneic hematopoietic stem cell transplantation—an old complication with new insights☆
10.1053/j.seminhematol.2018.08.004 · 2019 · External reference
Donor-Specific Antibodies and Primary Graft Failure in Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis
10.1016/j.jtct.2021.04.030 · 2021 · External reference
T cell replete–haploidentical second hematopoietic stem cell transplantation for primary graft failure in pediatric patients with hematologic malignancies
10.1111/petr.13043 · 2017 · External reference
Current and future approaches to treat graft failure after allogeneic hematopoietic stem cell transplantation
10.1517/14656566.2014.852537 · 2014 · External reference
Etiology and Outcome of Graft Failure in Pediatric Hematopoietic Stem Cell Transplant Recipients
10.1097/00043426-200312000-00010 · 2003 · External reference
Use of G-CSF-stimulated marrow in allogeneic hematopoietic stem cell transplantation settings: a comprehensive review
10.1111/j.1399-0012.2010.01298.x · 2011 · External reference
Use of recombinant human granulocyte-macrophage colony-stimulating factor in graft failure after bone marrow transplantation
10.1182/blood.v76.1.245.245 · 1990 · External reference
Second haploidentical stem cell transplantation for primary graft failure
10.1038/s41409-020-01183-9 · 2021 · External reference
Prognostic factors in salvage transplantation for graft failure following allogeneic hematopoietic stem cell transplantation
10.1038/s41409-021-01310-0 · 2021 · External reference
Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT
2024 · External reference
Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Th
10.1016/j.jtct.2021.04.007 · 2021 · External reference
Defining the Intensity of Conditioning Regimens: Working Definitions
10.1016/j.bbmt.2009.07.004 · 2009 · External reference
Iron Overload
2024 · External reference
Unresolved reference
2019 · External reference
International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium
10.1016/j.bbmt.2015.09.001 · 2016 · External reference
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report
10.1016/j.bbmt.2014.12.001 · 2015 · External reference
Significance of chimerism in hematopoietic stem cell transplantation: new variations on an old theme
10.1038/sj.bmt.1704525 · 2004 · External reference
Primary graft failure following allogeneic hematopoietic stem cell transplantation: risk factors, treatment and outcomes
10.1080/16078454.2022.2042064 · 2022 · External reference
Risk Factors for Primary and Secondary Graft Failure in Allogenic Hematopoietic Cell Transplantation: A Single Center Study
10.1182/blood-2019-124208 · 2019 · External reference
Outcome of graft failure after allogeneic stem cell transplant: study of 89 patients
10.3109/10428194.2014.930849 · 2015 · External reference
Second allogeneic hematopoietic cell transplantation for graft failure: poor outcomes for neutropenic graft failure
10.1002/ajh.24111 · 2015 · External reference
Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies
10.1038/leu.2015.75 · 2015 · External reference
Graft failure after allogeneic hematopoietic stem cell transplantation
2018 · External reference
Outcome of Second Conditioned Allogeneic Stem Cell Transplant in Children with Non-SCID Inborn Errors of Immunity
10.1182/bloodadvances.2025015971 · 2026 · External reference
Emerging drugs for prevention of graft failure after allogeneic hematopoietic stem cell transplantation
10.1517/14728214.2013.798642 · 2013 · External reference
10.1038/s41409-023-02012-5
10.1038/s41409-023-02012-5 · 2023 · External reference
Long-term follow-up of patients who experienced graft failure postallogeneic progenitor cell transplantation. Results of a single institution analysis
10.1016/j.bbmt.2008.05.005 · 2008 · External reference
Second unrelated donor hematopoietic cell transplantation for primary graft failure
10.1016/j.bbmt.2010.02.013 · 2010 · External reference
Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation
10.1038/sj.bmt.1703389 · 2002 · External reference
Outcomes Following Second Allogeneic Stem Cell Transplant for Graft Failure or Poor Graft Function: A Single Centre Experience
10.1007/s12015-025-10903-x · 2025 · External reference
The 2023 EBMT report on hematopoietic cell transplantation and cellular therapies. Increased use of allogeneic HCT for myeloid malignancies and of CAR-T at the expense of autologous HCT
10.1038/s41409-025-02524-2 · 2025 · External reference
Conditioning Regimens for Second Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Primary Graft Failure
10.1016/j.jtct.2025.06.007 · 2025 · External reference
Peripheral blood as a preferable source of stem cells for salvage transplantation in patients with graft failure after cord blood transplantation: a retrospective analysis of the registry data of the Japanese Society for Hematopoietic Cell Transplantation
10.1016/j.bbmt.2012.02.014 · 2012 · External reference
High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation
10.1097/tp.0b013e3181b9d710 · 2009 · External reference
Graft failure after allogeneic hematopoietic cell transplantation
10.1016/j.bbmt.2007.10.025 · 2008 · External reference
Graft failure after allogeneic hematopoietic stem cell transplantation in pediatric patients with acute leukemia: autologous reconstitution or second transplant?
10.1186/s13287-024-03726-z · 2024 · External reference
